GATX vs UTHR · P/E 19, rev $1.16B vs P/E 20, rev $1.56B
GATX Corporation (GATX) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
GATX Corporation (GATX) is a rental & leasing services company listed on NYSE.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported GATX revenue for 2026-06-30 was $1.16B. Net income was $188.9M. Revenue was up 99.4% from 2026-03-31 to 2026-06-30. GATX currently screens at market cap $6.23B and trailing P/E 18.8.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
GATX currently screens at market cap $6.23B and trailing P/E 18.8. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the GATX and UTHR stock pages for the full models.
Not investment advice.